Tandem Diabetes Care (TNDM) Financials: History & Chart

Tandem Diabetes Care, Inc.(TNDM)

Medical - Devices · San Diego, CA

$16.16-0.36 (-2.18%)

Delayed quote: Oct 6, 2026, 4:00 PM EDT

About Tandem Diabetes Care, Inc.

Tandem Diabetes Care, Inc., a medical technology firm, specializes in creating, developing, and marketing solutions for individuals globally who manage insulin-dependent diabetes. At the core of its offerings is the t:slim X2 insulin delivery system, an advanced pump platform that integrates the t:slim X2 pump, a disposable 300-unit insulin cartridge, and an infusion set. Tandem further enhances this platform with innovative features like Basal-IQ and Control-IQ technology, as well as G5 Integration capabilities. The company also provides the Tandem Device Updater, enabling users to easily update their pump's software. To facilitate therapy management, Tandem offers t:connect, a web-based application that visually presents diabetes data from the pump, continuous glucose monitoring (CGM) devices, and supported blood glucose meters to patients, their caregivers, and healthcare professionals. Additionally, the Sugarmate mobile application caters specifically to insulin users with diabetes. Tandem has strategic development and commercialization partnerships with leading companies such as Dexcom, Inc. and Abbott Laboratories. Established in 2006 and headquartered in San Diego, California, the company was initially known as Phluid Inc. before rebranding as Tandem Diabetes Care, Inc. in January 2008.

San Diego, CA

2,500 employees

www.tandemdiabetes.com

Healthcare / Medical - Devices

Sector: Healthcare
Industry: Medical - Devices
CEO: John F. Sheridan

View full financials

Financials

SEC Filings

Quarterly Income Statement (USD)

Swipe horizontally to review earlier periods. The line-item column stays pinned.

Quarterly Report	TTM	Quarter ended Jun 2026	Quarter ended Mar 2026	Quarter ended Dec 2025	Quarter ended Sep 2025	Quarter ended Jun 2025	Quarter ended Mar 2025	Quarter ended Dec 2024	Quarter ended Sep 2024
Revenue	1.04B	254.56M	247.22M	290.38M	249.25M	240.68M	234.42M	282.65M	363.29M
Cost of Goods Sold	458.10M	109.78M	110.43M	122.92M	114.96M	114.82M	116.02M	125.19M	238.64M
Gross Profit	583.32M	144.78M	136.79M	167.46M	134.29M	125.86M	118.41M	157.46M	124.65M
Gross Profit Margin	56.0%	56.9%	55.3%	57.7%	53.9%	52.3%	50.5%	55.7%	34.3%
Total Operating Expenses	626.32M	158.57M	154.22M	159.17M	154.35M	177.66M	239.28M	158.04M	150.75M
Research & Development	186.91M	46.93M	46.03M	46.07M	47.88M	48.12M	125.43M	52.20M	51.11M
Selling, General & Administrative	439.40M	111.64M	108.19M	113.10M	106.47M	109.60M	113.85M	105.84M	99.64M
Operating Income (EBIT)	-42.99M	-13.79M	-17.43M	8.29M	-20.06M	-51.81M	-120.88M	-582K	-26.09M
Operating Margin	-4.1%	-5.4%	-7.1%	2.9%	-8.0%	-21.5%	-51.6%	-0.2%	-7.2%
Income Before Tax (EBT)	-61.00M	-20.66M	-19.88M	4.68M	-25.14M	-57.72M	-122.09M	16K	-22.61M
Interest Income	10.38M	1.23M	3.63M	3.02M	2.51M	N/A	4.19M	4.51M	5.34M
Interest Expense	8.22M	2.45M	1.63M	2.08M	2.06M	2.54M	1.36M	1.86M	1.86M
Other Income/Expense	-18.00M	-6.87M	-2.44M	-3.61M	-5.08M	-5.91M	-1.21M	598K	3.48M
Net Income	-63.31M	-21.17M	-20.39M	-589K	-21.16M	-52.40M	-130.56M	755K	-23.25M
Income Tax Expense	2.32M	510K	516K	5.27M	-3.98M	-5.32M	8.47M	-739K	637K
Net Profit Margin	-6.1%	-8.3%	-8.2%	-0.2%	-8.5%	-21.8%	-55.7%	0.3%	-6.4%
EBITDA	-20.53M	-4.82M	-12.93M	12.79M	-15.57M	-47.44M	-116.57M	3.66M	-21.88M
EBITDA Margin	-2.0%	-1.9%	-5.2%	4.4%	-6.2%	-19.7%	-49.7%	1.3%	-6.0%
Depreciation & Amortization	22.47M	8.97M	4.50M	4.50M	4.49M	4.37M	4.31M	4.25M	4.21M
EPS Basic	-0.93	-0.31	-0.30	-0.01	-0.31	-0.78	-1.97	0.01	-0.35
EPS Diluted	-0.93	-0.31	-0.30	-0.01	-0.31	-0.78	-1.97	0.01	-0.35
Weighted Average Basic Shares	68.40M	68.40M	68.40M	68.01M	67.65M	67.05M	66.40M	65.94M	65.54M
Weighted Average Diluted Shares	68.40M	68.40M	68.40M	68.01M	67.65M	67.05M	66.40M	66.16M	65.54M

Annual Income Statement (USD)

Swipe horizontally to review earlier years. The line-item column stays pinned.

Annual Report	12/31/2025	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018
Revenue	1.01B	940.20M	747.72M	801.22M	702.80M	498.83M	362.31M	183.87M
Cost of Goods Sold	483.89M	450.63M	380.03M	388.23M	326.58M	238.31M	168.09M	94.04M
Gross Profit	530.85M	489.57M	367.69M	412.99M	376.21M	260.52M	194.21M	89.82M
Gross Profit Margin	52.3%	52.1%	49.2%	51.5%	53.5%	52.2%	53.6%	48.9%
Total Operating Expenses	608.97M	588.70M	600.92M	505.83M	353.56M	268.48M	210.93M	134.45M
Research & Development	174.84M	198.88M	248.42M	170.15M	92.05M	63.57M	45.20M	29.23M
Selling, General & Administrative	434.13M	389.82M	352.50M	335.68M	261.51M	204.90M	165.74M	105.23M
Operating Income (EBIT)	-78.12M	-99.13M	-233.23M	-92.85M	22.65M	-7.96M	-16.72M	-44.63M
Operating Margin	-7.7%	-10.5%	-31.2%	-11.6%	3.2%	-1.6%	-4.6%	-24.3%
Income Before Tax (EBT)	-200.27M	-91.87M	-220.25M	-92.85M	15.90M	-36.28M	-24.60M	-122.56M
Interest Income	9.09M	17.99M	22.86M	6.06M	674K	1.57M	3.27M	1.46M
Interest Expense	7.91M	7.42M	9.88M	6.21M	6.04M	12.80M	78K	7.58M
Other Income/Expense	-122.15M	7.26M	12.98M	-4K	-6.75M	-28.32M	-7.88M	-77.93M
Net Income	-204.71M	-96.03M	-222.61M	-94.59M	15.57M	-34.38M	-24.75M	-122.61M
Income Tax Expense	4.44M	4.16M	2.36M	1.74M	335K	-1.90M	149K	51K
Net Profit Margin	-20.2%	-10.2%	-29.8%	-11.8%	2.2%	-6.9%	-6.8%	-66.7%
EBITDA	-60.46M	-98.97M	-217.51M	-78.52M	36.50M	2.49M	-10.65M	-38.81M
EBITDA Margin	-6.0%	-10.5%	-29.1%	-9.8%	5.2%	0.5%	-2.9%	-21.1%
Depreciation & Amortization	17.67M	158K	15.71M	14.33M	13.85M	10.45M	6.07M	5.82M
EPS Basic	-3.04	-1.47	-3.43	-1.47	0.25	-0.56	-0.42	-2.55
EPS Diluted	-3.04	-1.47	-3.43	-1.47	0.24	-0.56	-0.42	-2.55
Weighted Average Basic Shares	67.28M	65.45M	64.90M	64.15M	63.00M	60.99M	58.51M	48.13M
Weighted Average Diluted Shares	67.28M	65.45M	64.97M	64.15M	64.35M	60.99M	58.51M	48.13M

Values are displayed in USD. Negative numbers shown in red.

Values are displayed in USD. Negative numbers are shown in red.